LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
LENSAR, Inc.NASDAQ: LNSR
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue grows, but more slowly than its trailing trend
Q1 FY2026 cost of revenue of $7.05M rose 0.2% year over year, behind the +5.2% change in trailing-twelve-month cost of revenue. Sequentially, it fell 22.5% from the prior quarter. Over 3 fiscal years it compounded at +26.7% a year.
Context
- Cost of revenue amounted to 53.6% of revenue in FY2025, up 1.9 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +0.2% toward the trailing-twelve-month pace of +5.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 31.31M USD
- Year-over-year change
- +13.3%
- 4-year CAGR
- +17.1%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 31.31M | +13.3% |
| FY2024 | 2024-12-31 | 27.64M | +31.3% |
| FY2023 | 2023-12-31 | 21.06M | +36.7% |
| FY2022 | 2022-12-31 | 15.4M | -7.4% |
| FY2021 | 2021-12-31 | 16.63M | — |
Cost of Revenue vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 cost of revenue of $31.55M is the 3rd highest of the 10 companies compared; the peer median is $6.7M.
- Its year-over-year change of +5.2% is the 8th highest of 10, against a peer median of +17.1%.
- Cost of revenue amounts to 54.7% of revenue for LNSR, versus a peer median of 45.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $52.61M | +30.6% | +4.4% | 49.1% | |
| LTM Mar 2026 | $48.14M | +36.8% | +6.5% | 41.4% | |
| LTM Mar 2026 | $31.55M | +5.2% | +26.7% | 54.7% | |
| LTM Mar 2026 | $30.12M | +8.2% | +0.4% | 87.6% | |
| LTM Mar 2026 | $11.58M | +18.8% | — | 2205.7% | |
| LTM Mar 2026 | $6.7M | +44.8% | +45.6% | 14.9% | |
| LTM Mar 2026 | $6.23M | -13.4% | +6.9% | 19.3% | |
| LTM Mar 2026 | $5.46M | +17.1% | +9.4% | 28.9% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $1.33M | +13.5% | -8.4% | 71.7% |
| LTM Mar 2026 | $149K | -99.1% | — | — | |
| Peer median (excluding LNSR) | $6.7M | +17.1% | +6.5% | 45.3% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 34.46M | 35.36M | 42.16M | 53.49M | 58.44M |
| Cost of Revenue | 16.63M | 15.4M | 21.06M | 27.64M | 31.31M |
| Gross Profit | 17.83M | 19.96M | 21.11M | 25.85M | 27.12M |
| Gross Margin | 51.8% | 56.4% | 50.1% | 48.3% | 46.4% |
| Research & Development | 12.36M | 11.81M | 6.14M | 5.33M | 5.62M |
| Selling, General & Admin | 23.89M | 27.17M | 26.1M | 26.49M | 45.16M |
| Operating Expenses | 37.49M | 40.13M | 33.34M | 36.52M | 51.7M |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| EBITDA | (16.84M) | (16.51M) | (10.87M) | (3.01M) | (29.78M) |
| EBITDA Margin | -48.9% | -46.7% | -25.8% | -5.6% | -51.0% |
| Operating Income | (19.65M) | (20.18M) | (12.23M) | (10.67M) | (24.58M) |
| Operating Margin | -57.0% | -57.1% | -29.0% | -19.9% | -42.1% |
| Interest Income | 34K | 17K | 85K | 103K | 91K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 51K | 263K | (2.15M) | (20.74M) | (9.7M) |
| Income Before Tax | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Pre-Tax Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Net Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| EPS (Basic) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| EPS (Diluted) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| Weighted Avg Shares | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
| Weighted Avg Shares (Diluted) | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.